Age (yr) (mean ± SD) (range) | 59 ± 15.4, 24–87 |
Men | 79 (72.5%) |
Definite IEb | 84 (77%) |
Possible IEb | 25 (23%) |
Previous history of IE | 13 (12%) |
Microorganism | |
Oral streptococci | 27 (25%) |
Group D streptococci | 8 (7%) |
Enterococci | 8 (7%) |
Staphylococcus aureus | 26 (24%) |
Coagulase-negative staphylococci | 5 (4.5%) |
Other microorganism or >1 microorganism | 14 (13%) |
No microorganism identified | 21 (19%) |
Prosthetic valve IE | 32 (29%) |
IE on native valve | |
Aortic | 17 (15.5%) |
Mitral | 39 (36%) |
Aortic and mitral | 10 (9%) |
Tricuspid | 7 (6.5%) |
Other | 4 (4%) |
Prior anticoagulant or antiplatelet agent therapy | 36 (33%) |